Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

10x Genomics (TXG) R&D In Process (2018 - 2020)

10x Genomics' R&D In Process history spans 2 years, with the latest figure at $406.9 million for Q4 2020.

  • For Q4 2020, R&D In Process changed N/A year-over-year to $406.9 million; the TTM value through Dec 2021 reached $447.5 million, down 8.21%, while the annual FY2020 figure was $447.5 million, N/A changed from the prior year.
  • R&D In Process for Q4 2020 was $406.9 million at 10x Genomics, up from $40.6 million in the prior quarter.
  • Across five years, R&D In Process topped out at $406.9 million in Q4 2020 and bottomed at $40.1 million in Q4 2018.